5
Clinical Trials associated with Henagliflozein Proline/Retagliptin Phosphate/Metformin Hydrochloride / CompletedNot Applicable [Translation] Bioequivalence study of HR20031 tablets in healthy subjects
主要研究目的:评价健康受试者高脂餐后状态下单次口服受试制剂 HR20031 片和参比制剂脯氨酸恒格列净片、磷酸瑞格列汀、盐酸二甲双胍缓释片的生物等效性;
次要研究目的:评价健康受试者高脂餐后状态下单次口服受试制剂 HR20031 片和参比制剂脯氨酸恒格列净片、磷酸瑞格列汀、盐酸二甲双胍缓释片的安全性。
[Translation] The main purpose of the study is to evaluate the bioequivalence of the test preparation HR20031 tablets and the reference preparations of proline henggliflozin tablets, retagliptin phosphate, and metformin hydrochloride sustained-release tablets after a single oral administration in healthy subjects in the post-high-fat meal state;
The secondary purpose of the study is to evaluate the safety of the test preparation HR20031 tablets and the reference preparations of proline henggliflozin tablets, retagliptin phosphate, and metformin hydrochloride sustained-release tablets after a single oral administration in healthy subjects in the post-high-fat meal state.
A Bioequivalence Study of HR20031 Tablet in Healthy Subjects
The purpose of this study is to assess the bioequivalence between HR20031 FDC tablet and co-administration of SHR3824 tablets, SP2086 tablets and metformin XR tablets.
A Study to Assess the Effect of Food on HR20031 Tablet in Healthy Subjects
The purpose of this study is to assess the effect of food on the single-dose PK of SHR3824, SP2086 and metformin in the HR20031 FDC tablets in healthy subjects.
100 Clinical Results associated with Henagliflozein Proline/Retagliptin Phosphate/Metformin Hydrochloride
100 Translational Medicine associated with Henagliflozein Proline/Retagliptin Phosphate/Metformin Hydrochloride
100 Patents (Medical) associated with Henagliflozein Proline/Retagliptin Phosphate/Metformin Hydrochloride
100 Deals associated with Henagliflozein Proline/Retagliptin Phosphate/Metformin Hydrochloride